http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CZ-347697-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c2b9dc89cc4ba060cc73bbf0c90bbb78 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D477-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D477-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-397 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D477-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D477-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D477-00 |
| filingDate | 1996-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f689982dcac064daf9f0b59b24b4dc6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f7e530dbc217e27406c0b946d1c8f5a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abb69801dda27477d8a247d28ece4e4b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc06b2125a9eea6ac88d1f5e3e6cce41 |
| publicationDate | 1998-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CZ-347697-A3 |
| titleOfInvention | Carbapenem ester esters, processes for their preparation and pharmaceutical compositions containing them |
| abstract | A compound of general formula (I) in which R is (a); wherein R< alpha > is hydrogen, optionally substituted (C1-6)alkyl or optionally substituted aryl; R< beta > is hydrogen, optionally substituted (C1-6)alkyl or optionally substituted aryl; or R< alpha > and R< beta > together form an optionally substituted 5 or 6 membered heterocyclic ring with or without additional heteroatoms; R<1> is (C1-6)alkyl which is unsubstituted or substituted by fluoro, a hydroxy group which is optionally protected by a readily removable hydroxy protecting group, or by an amino group which is optionally protected by a readily removable amino protecting group; R<2> is hydrogen or methyl; and R<3> is selected from the group consisting of (a) a group of formula (i) wherein R1 is hydrogen or (C1-6)alkyl, R2 is hydrogen, (C1-6)alkyl optionally substituted by halogen, (C1-6)alkenyl, (C1-6)alkoxycarbonyl, aryl, or heteroaryl, R3 is hydrogen, (C1-6)alkyl, or (C1-6)alkoxycarbonyl, and R4 is a pharmaceutically acceptable ester forming group, and (b) a group of formula CH(R<a>)O.CO.R<b>, wherein R<a> is hydrogen, (C1-6)alkyl, (C3-7)cycloalkyl, methyl, or phenyl; and R<b> is (C1-6)alkyl(C3-7)cycloalkyloxy or (C1-6)alkoxy(C1-6)alkyl, is useful in the treatment of bacterial infections. |
| priorityDate | 1995-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 132.